Rimon
Save as PDF RSS Feed Subscribe

Entries tagged “Matrixx”

Supreme Court Rejects “Statistical Significance” as Threshold for Required Securities Disclosure

Insight April 06, 2011

In Matrixx Initiatives et al. v. Siracusano et al, the unanimous Court held that a pharmaceutical company may be liable for securities fraud by failing to disclose a statistically insignificant number of adverse reactions to a cold medication.  

            

Continue Reading…